DENTALI, FRANCESCO
 Distribuzione geografica
Continente #
AS - Asia 845
EU - Europa 497
NA - Nord America 370
SA - Sud America 347
AF - Africa 276
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 10
Totale 2.382
Nazione #
BR - Brasile 244
HK - Hong Kong 220
US - Stati Uniti d'America 208
PL - Polonia 135
CN - Cina 109
VN - Vietnam 89
SG - Singapore 87
DE - Germania 42
NL - Olanda 37
TR - Turchia 22
AR - Argentina 21
KR - Corea 21
IT - Italia 19
ZA - Sudafrica 19
FR - Francia 18
RU - Federazione Russa 17
GT - Guatemala 15
SE - Svezia 15
AE - Emirati Arabi Uniti 14
KG - Kirghizistan 14
MX - Messico 14
NI - Nicaragua 14
CI - Costa d'Avorio 13
IQ - Iraq 13
AL - Albania 12
BZ - Belize 12
CL - Cile 12
ID - Indonesia 12
JO - Giordania 12
JP - Giappone 12
LB - Libano 12
ZM - Zambia 12
BB - Barbados 11
DK - Danimarca 11
EC - Ecuador 11
LA - Repubblica Popolare Democratica del Laos 11
LU - Lussemburgo 11
PE - Perù 11
PH - Filippine 11
TH - Thailandia 11
AM - Armenia 10
AU - Australia 10
CH - Svizzera 10
CO - Colombia 10
FI - Finlandia 10
IN - India 10
JM - Giamaica 10
KH - Cambogia 10
MZ - Mozambico 10
NP - Nepal 10
TN - Tunisia 10
VE - Venezuela 10
BA - Bosnia-Erzegovina 9
BD - Bangladesh 9
BO - Bolivia 9
BW - Botswana 9
CR - Costa Rica 9
CY - Cipro 9
GR - Grecia 9
IE - Irlanda 9
NC - Nuova Caledonia 9
PA - Panama 9
PS - Palestinian Territory 9
RS - Serbia 9
SA - Arabia Saudita 9
SD - Sudan 9
SI - Slovenia 9
TJ - Tagikistan 9
UG - Uganda 9
YE - Yemen 9
BE - Belgio 8
CM - Camerun 8
DZ - Algeria 8
ET - Etiopia 8
GE - Georgia 8
LV - Lettonia 8
MA - Marocco 8
ML - Mali 8
MN - Mongolia 8
PY - Paraguay 8
SK - Slovacchia (Repubblica Slovacca) 8
VC - Saint Vincent e Grenadine 8
AD - Andorra 7
AF - Afghanistan, Repubblica islamica di 7
CU - Cuba 7
CZ - Repubblica Ceca 7
DO - Repubblica Dominicana 7
LY - Libia 7
MD - Moldavia 7
MY - Malesia 7
PF - Polinesia Francese 7
PT - Portogallo 7
RE - Reunion 7
SN - Senegal 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
BF - Burkina Faso 6
CG - Congo 6
CV - Capo Verde 6
EG - Egitto 6
Totale 2.103
Città #
Hong Kong 212
Bytom 127
Singapore 81
Hefei 50
Los Angeles 34
Buffalo 33
Ho Chi Minh City 33
Beijing 32
Munich 31
Redondo Beach 25
Chicago 19
Hanoi 18
São Paulo 15
Managua 13
Amman 12
Lusaka 12
Seoul 12
Abidjan 11
Ashburn 11
Bishkek 11
Guatemala City 10
Phnom Penh 10
Bridgetown 9
Dushanbe 9
Panama City 9
Sanaa 9
Vientiane 9
Yerevan 9
Johannesburg 8
Kampala 8
Kingstown 8
Mexico City 8
Noumea 8
Salt Lake City 8
Tirana 8
Turku 8
Ulan Bator 8
Andorra la Vella 7
Bamako 7
Dakar 7
Düsseldorf 7
Havana 7
Lima 7
Luxembourg 7
Maputo 7
Riga 7
Rio de Janeiro 7
Tbilisi 7
Antananarivo 6
Athens 6
Baku 6
Bangkok 6
Belo Horizonte 6
Biên Hòa 6
Conakry 6
Dili 6
Istanbul 6
Kingston 6
Libreville 6
Papeete 6
San José 6
Tashkent 6
Accra 5
Amsterdam 5
Auckland 5
Belgrade 5
Belize City 5
Brasília 5
Brussels 5
Cape Town 5
Casablanca 5
Castries 5
Cotonou 5
Curitiba 5
Limassol 5
Ljubljana 5
Montevideo 5
Nassau 5
Pristina 5
Riyadh 5
Sydney 5
Tunis 5
Abu Dhabi 4
Baghdad 4
Caruaru 4
Copenhagen 4
Da Nang 4
Dar es Salaam 4
Douala 4
Dublin 4
Frankfurt am Main 4
Gaborone 4
Guayaquil 4
Haiphong 4
Harare 4
Kathmandu 4
Khartoum 4
Kigali 4
La Paz 4
Lauterbourg 4
Totale 1.271
Nome #
Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome 61
Rates of venous thromboembolism and use of thromboprophylaxis after major orthopedic surgery in patients with congenital hemophilia A or B: a systematic review 60
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment 48
Hypoalbuminaemia and heart failure: A practical review of current evidence 47
Rapid salivary test suitable for a mass screening program to detect SARS-CoV-2: a diagnostic accuracy study 39
Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs 39
Prognostic role of neutrophils to lymphocytes ratio in patients with acute pulmonary embolism: a systematic review and meta-analysis of the literature 38
Management and Outcomes of Isolated Distal Deep Vein Thromboses: A Questionable Trend toward Long-Lasting Anticoagulation Treatment. Results from the START-Register 38
The Clinical Impact of the Pulmonary Embolism Severity Index on the Length of Hospital Stay of Patients with Pulmonary Embolism: A Randomized Controlled Trial 37
Sex-related characteristics of cerebral vein thrombosis: A secondary analysis of a multicenter international cohort study 37
Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: Randomised controlled trial 36
In vitro effects of Apixaban on 5 different cancer cell lines 36
Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy 35
Chronobiologic Aspects of Venous Thromboembolism 35
Association between ABCG2 and ABCB1 genes and warfarin stability: a case-control study 35
Systematic review: neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularization 35
Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis 34
SOA XIX: Lipid-lowering drugs and haemostasis 34
The role of thrombolytic therapy in pulmonary embolism 33
Portal vein thrombosis in decompensated cirrhosis: rationale for treatment 33
Residual vein obstruction in patients diagnosed with acute isolated distal deep vein thrombosis associated with active cancer 33
Vena Cava Filters and In-Hospital Case Fatality Among Patients With Pulmonary Embolism: Results From a Large Population-Based Study 32
Mild antithrombin deficiency and risk of recurrent venous thromboembolism: a prospective cohort study 31
Clinical course of isolated distal deep vein thrombosis in patients with active cancer: a multicenter cohort study 31
SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients 31
Statins for acute ischemic stroke 30
The effect of recanalization on long-term neurological outcome after cerebral venous thrombosis 30
In-hospital mortality due to pulmonary embolism in patients with Alzheimer disease: A sex effect? 29
Incidence of symptomatic and asymptomatic chronic pulmonary hypertension in patients with a previous episode of pulmonary embolism: a prospective cohort study 29
Cardiovascular disease and venous thromboembolism. Different disorders or possible intriguing association? 27
Incidence rates and case-fatality rates of cerebral vein thrombosis: A population-based study 26
Diagnostic accuracy of lung ultrasound for pulmonary embolism: a systematic review and meta-analysis 26
Thromboprophylaxis in Acutely Ill Medical Patients: Results of A Survey Among Italian Physicians 25
Direct oral anticoagulants for superficial-vein thrombosis 25
The effect of thyroid autoantibodies on warfarin stability 25
Incidence of deep vein Thrombosis following gynecologic laparoscopy: a prospective cohort study 25
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature: a reply to a rebuttal 25
External validation of the DASH prediction rule: a retrospective cohort study 24
Natural anticoagulants deficiency and the risk of venous thromboembolism: A meta-analysis of observational studies 24
Warfarin interactions with antibiotics in the ambulatory care setting 23
Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases 23
Pulmonary embolism prognostic factors and length of hospital stay: A cohort study 23
Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: A multicenter retrospective cohort study 23
Is diabetes a hypercoagulable state? A critical appraisal 23
Major Bleeding and Case Fatality Rate with the Direct Oral Anticoagulants in Orthopedic Surgery: A Systematic Review and Meta-Analysis 22
Clinical utility of antithrombotic prophylaxis in ART procedures: an Italian experience 22
Effect of Vitamin K Intake on the Stability of Treatment with Vitamin K Antagonists: A Systematic Review of the Literature 22
Direct oral anticoagulants for the treatment of acute venous thromboembolism in patients with cancer: a meta-analysis of randomised controlled trials 22
Antithrombin levels and the risk of a first episode of venous thromboembolism: a case-control study 22
Low-molecular -weight heparin in pregnancies after ART -A retrospective study- 22
Optimal treatment duration of venous thrombosis 22
Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature 22
The metabolic syndrome and the risk of thrombosis 22
Patient selection for thromboprophylaxis in medical inpatients 21
The initial phase of oral anticoagulation with warfarin in outpatients with deep venous thrombosis 21
Role of ABO blood group and of other risk factors on the presence of residual vein obstruction after deep-vein thrombosis 20
How can we improve the diagnosis of deep vein thrombosis and pulmonary embolism at the primary level? 20
Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy 20
Pregnancy-related venous thrombosis: Comparison between spontaneous and ART conception in an Italian cohort 20
Location of venous thrombosis in patients with FVL or prothrombin G20210A mutations: Systematic review and meta-analysis 20
Risk of recurrence of unusual site venous thromboembolism 20
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage 20
Prevention and treatment of venous thromboembolism in patients with solid brain neoplasms: results of a survey among Italian physicians 20
A survey of thrombosis prophylaxis use in patients undergoing arthroscopic surgery 20
Diagnosis and management of venous thromboembolism: Results of a survey on current clinical practice 20
Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism: A multicentre retrospective cohort study 19
Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome 19
Thrombosis prophylaxis in medical patients: a retrospective review of clinical practice patterns 19
Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding 19
Italian intersociety consensus on DOAC use in internal medicine 19
Unsuspected pulmonary embolism in cancer patients: a narrative review with pooled data 19
Unmet clinical needs in the managementof patients with splanchnic vein thrombosis 19
Risk factors for suboptimal efficacy of 3-factor prothrombin complex concentrates in emergency vka anticoagulation reversal 19
How I treat splanchnic vein thrombosis 19
Relationship between ABO blood group and hemorrhage: a systematic literature review and meta-analysis 18
Diagnostic accuracy of magnetic resonance imaging in patients with suspected pulmonary embolism: A bivariate meta-analysis 18
ABO blood group and vascular disease: an update 18
incidence of thromboembolic complications in patients with mechanical heart valves with a subtherapeutic international normalized ratio 18
Nonadherence with INR monitoring and anticoagulant complications 18
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature 18
Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry 18
The association between neonatal ABO blood group and intraventricular hemorrhage in extremely low birth weight infants: A reply to a comment 17
Antithrombotic treatment of splanchnic vein thrombosis: results of an international registry 17
Chronobiology of acute aortic rupture or dissection: A systematic review and a meta-analysis of the literature 17
Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature 17
Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism 17
Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes 17
Polymorphisms of the Z protein protease inhibitor and risk of venous thromboembolism: a meta-analysis 17
The prevention and treatment of venous thromboembolism in pregnancy 16
Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism: Comment 16
In-hospital mortality for pulmonary embolism: relationship with chronic kidney disease and end-stage renal disease. The hospital admission and discharge database of the Emilia Romagna region of Italy 16
Statins and secondary prevention of ischemic and hemorrhagic stroke 16
Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomised controlled trial 16
Management of primary care patients with suspected deep vein thrombosis: use of a therapeutic dose of low-molecular-weight heparin to avoid urgent ultrasonographic evaluation 16
The new oral anticoagulants, do they change the benefit vs. risk for thromboprophylaxis in association to ambulatory surgery? 15
The role of inherited thrombophilia in patients with isolated pulmonary embolism: a systematic review and a meta-analysis of the literature 15
Low-dose aspirin for in vitro fertilization or intracytoplasmic sperm injection: a systematic review and a meta-analysis of the literature 14
Risk of Thromboembolism, Recurrent Hemorrhage, and Death after Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding 14
Pulmonary Embolism Severity Index Accurately Predicts Long-Term Mortality Rate In Patients Hospitalized For Acute Pulmonary Embolism 14
Clinical Pregnancies and Live Births in women approaching ART: a follow-up analysis of 157 women after thrombophilia screening 13
Totale 2.470
Categoria #
all - tutte 5.260
article - articoli 5.001
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.261


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025820 0 0 0 0 0 0 0 0 0 140 259 421
2025/20261.663 158 359 1.146 0 0 0 0 0 0 0 0 0
Totale 2.483